Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

343 recalls, newest first

Class II · Moderate risk

Lipoic Acid 25mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0640-2018
Class II · Moderate risk

HCG 1000 units/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0639-2018
Class II · Moderate risk

Glutathione 200mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0638-2018
Class II · Moderate risk

CoEnzymeQ10 25mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0637-2018
Class II · Moderate risk

Biotin Suspension 10mg/mL

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0636-2018
Class II · Moderate risk

Ascorbic Acid

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Terminated Sterility / contamination Partell Specialty Pharmacy D-0634-2018
Class I · High risk

Hydromorphone

Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.

Terminated Sterility / contamination Pfizer Inc. D-0597-2018
Class I · High risk

Hydromorphone

Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked.

Terminated Sterility / contamination Pfizer Inc. D-0596-2018
Class II · Moderate risk

100 mcg / mL Phenylephrine HCl

Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.

Terminated Sterility / contamination PharMEDium Services, LLC D-0424-2018
Class II · Moderate risk

0.2% Ropivacaine HCI

Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.

Terminated Sterility / contamination PharMEDium Services, LLC D-0423-2018

Recalls by year